A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32).
W. Parulekar
No relevant relationships to disclose
B. E. Chen
No relevant relationships to disclose
C. Elliott
No relevant relationships to disclose
L. E. Shepherd
No relevant relationships to disclose
K. A. Gelmon
No relevant relationships to disclose
K. I. Pritchard
Honoraria - Abraxis BioScience; Boehringer Ingelheim; Novartis; Pfizer; Roche
Expert Testimony - AstraZeneca (U); Novartis (U)
T. J. Whelan
No relevant relationships to disclose
J. A. Ligibel
No relevant relationships to disclose
D. L. Hershman
No relevant relationships to disclose
I. A. Mayer
No relevant relationships to disclose
T. J. Hobday
No relevant relationships to disclose
P. Rastogi
No relevant relationships to disclose
J. Lemieux
No relevant relationships to disclose
P. A. Ganz
No relevant relationships to disclose
V. Stambolic
No relevant relationships to disclose
P. J. Goodwin
Research Funding - Novartis